Rivaroxaban for Improvement of Thromboembolism Outcomes in Patients With Multiple Myeloma on Lenalidomide-based Therapy: RithMM Trial
Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Aspirin (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms RithMM
- 31 Aug 2018 Biomarkers information updated
- 27 Jun 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jul 2018.
- 05 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.